Recombinant Coagulation Factors Market Forecast to 2028 - COVID-19 Impact and Global Analysis By : Product (Recombinant Factor Viii, Recombinant Factor IX, Von Willebrand Factor); Hemophilia Type (Hemophilia A Hemophilia B); End User (Hospitals, Clinics, Research Institutes)
Report Code: TIPRE00017828 | No. of Pages: 150 | Category: Biotechnology | Status: Upcoming
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Recombinant Coagulation Factors Market - By Product
1.3.2 Recombinant Coagulation Factors Market - By Hemophilia Type
1.3.3 Recombinant Coagulation Factors Market - By End User
1.3.4 Recombinant Coagulation Factors Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RECOMBINANT COAGULATION FACTORS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 Europe - Pest Analysis
4.2.2 Asia-Pacific - Pest Analysis
4.2.3 Middle East and Africa - Pest Analysis
4.2.4 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RECOMBINANT COAGULATION FACTORS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RECOMBINANT COAGULATION FACTORS MARKET - GLOBAL MARKET ANALYSIS
6.1. RECOMBINANT COAGULATION FACTORS - GLOBAL MARKET OVERVIEW
6.2. RECOMBINANT COAGULATION FACTORS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. RECOMBINANT COAGULATION FACTORS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. RECOMBINANT FACTOR VIII
7.3.1. Overview
7.3.2. Recombinant Factor Viii Market Forecast and Analysis
7.4. RECOMBINANT FACTOR IX
7.4.1. Overview
7.4.2. Recombinant Factor IX Market Forecast and Analysis
7.5. VON WILLEBRAND FACTOR
7.5.1. Overview
7.5.2. Von Willebrand Factor Market Forecast and Analysis
8. RECOMBINANT COAGULATION FACTORS MARKET - REVENUE AND FORECASTS TO 2028 - HEMOPHILIA TYPE
8.1. OVERVIEW
8.2. HEMOPHILIA TYPE MARKET FORECASTS AND ANALYSIS
8.3. HEMOPHILIA A HEMOPHILIA B
8.3.1. Overview
8.3.2. Hemophilia A Hemophilia B Market Forecast and Analysis
9. RECOMBINANT COAGULATION FACTORS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. RESEARCH INSTITUTES
9.5.1. Overview
9.5.2. Research Institutes Market Forecast and Analysis
10. RECOMBINANT COAGULATION FACTORS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. EUROPE
10.1.1 Europe Recombinant Coagulation Factors Market Overview
10.1.2 Europe Recombinant Coagulation Factors Market Forecasts and Analysis
10.1.3 Europe Recombinant Coagulation Factors Market Forecasts and Analysis - By Product
10.1.4 Europe Recombinant Coagulation Factors Market Forecasts and Analysis - By Hemophilia Type
10.1.5 Europe Recombinant Coagulation Factors Market Forecasts and Analysis - By End User
10.1.6 Europe Recombinant Coagulation Factors Market Forecasts and Analysis - By Countries
10.1.6.1 Germany Recombinant Coagulation Factors Market
10.1.6.1.1 Germany Recombinant Coagulation Factors Market by Product
10.1.6.1.2 Germany Recombinant Coagulation Factors Market by Hemophilia Type
10.1.6.1.3 Germany Recombinant Coagulation Factors Market by End User
10.1.6.2 France Recombinant Coagulation Factors Market
10.1.6.2.1 France Recombinant Coagulation Factors Market by Product
10.1.6.2.2 France Recombinant Coagulation Factors Market by Hemophilia Type
10.1.6.2.3 France Recombinant Coagulation Factors Market by End User
10.1.6.3 Italy Recombinant Coagulation Factors Market
10.1.6.3.1 Italy Recombinant Coagulation Factors Market by Product
10.1.6.3.2 Italy Recombinant Coagulation Factors Market by Hemophilia Type
10.1.6.3.3 Italy Recombinant Coagulation Factors Market by End User
10.1.6.4 Spain Recombinant Coagulation Factors Market
10.1.6.4.1 Spain Recombinant Coagulation Factors Market by Product
10.1.6.4.2 Spain Recombinant Coagulation Factors Market by Hemophilia Type
10.1.6.4.3 Spain Recombinant Coagulation Factors Market by End User
10.1.6.5 United Kingdom Recombinant Coagulation Factors Market
10.1.6.5.1 United Kingdom Recombinant Coagulation Factors Market by Product
10.1.6.5.2 United Kingdom Recombinant Coagulation Factors Market by Hemophilia Type
10.1.6.5.3 United Kingdom Recombinant Coagulation Factors Market by End User
10.1.6.6 Rest of Europe Recombinant Coagulation Factors Market
10.1.6.6.1 Rest of Europe Recombinant Coagulation Factors Market by Product
10.1.6.6.2 Rest of Europe Recombinant Coagulation Factors Market by Hemophilia Type
10.1.6.6.3 Rest of Europe Recombinant Coagulation Factors Market by End User
10.2. ASIA-PACIFIC
10.2.1 Asia-Pacific Recombinant Coagulation Factors Market Overview
10.2.2 Asia-Pacific Recombinant Coagulation Factors Market Forecasts and Analysis
10.2.3 Asia-Pacific Recombinant Coagulation Factors Market Forecasts and Analysis - By Product
10.2.4 Asia-Pacific Recombinant Coagulation Factors Market Forecasts and Analysis - By Hemophilia Type
10.2.5 Asia-Pacific Recombinant Coagulation Factors Market Forecasts and Analysis - By End User
10.2.6 Asia-Pacific Recombinant Coagulation Factors Market Forecasts and Analysis - By Countries
10.2.6.1 Australia Recombinant Coagulation Factors Market
10.2.6.1.1 Australia Recombinant Coagulation Factors Market by Product
10.2.6.1.2 Australia Recombinant Coagulation Factors Market by Hemophilia Type
10.2.6.1.3 Australia Recombinant Coagulation Factors Market by End User
10.2.6.2 China Recombinant Coagulation Factors Market
10.2.6.2.1 China Recombinant Coagulation Factors Market by Product
10.2.6.2.2 China Recombinant Coagulation Factors Market by Hemophilia Type
10.2.6.2.3 China Recombinant Coagulation Factors Market by End User
10.2.6.3 India Recombinant Coagulation Factors Market
10.2.6.3.1 India Recombinant Coagulation Factors Market by Product
10.2.6.3.2 India Recombinant Coagulation Factors Market by Hemophilia Type
10.2.6.3.3 India Recombinant Coagulation Factors Market by End User
10.2.6.4 Japan Recombinant Coagulation Factors Market
10.2.6.4.1 Japan Recombinant Coagulation Factors Market by Product
10.2.6.4.2 Japan Recombinant Coagulation Factors Market by Hemophilia Type
10.2.6.4.3 Japan Recombinant Coagulation Factors Market by End User
10.2.6.5 South Korea Recombinant Coagulation Factors Market
10.2.6.5.1 South Korea Recombinant Coagulation Factors Market by Product
10.2.6.5.2 South Korea Recombinant Coagulation Factors Market by Hemophilia Type
10.2.6.5.3 South Korea Recombinant Coagulation Factors Market by End User
10.3. MIDDLE EAST AND AFRICA
10.3.1 Middle East and Africa Recombinant Coagulation Factors Market Overview
10.3.2 Middle East and Africa Recombinant Coagulation Factors Market Forecasts and Analysis
10.3.3 Middle East and Africa Recombinant Coagulation Factors Market Forecasts and Analysis - By Product
10.3.4 Middle East and Africa Recombinant Coagulation Factors Market Forecasts and Analysis - By Hemophilia Type
10.3.5 Middle East and Africa Recombinant Coagulation Factors Market Forecasts and Analysis - By End User
10.3.6 Middle East and Africa Recombinant Coagulation Factors Market Forecasts and Analysis - By Countries
10.3.6.1 South Africa Recombinant Coagulation Factors Market
10.3.6.1.1 South Africa Recombinant Coagulation Factors Market by Product
10.3.6.1.2 South Africa Recombinant Coagulation Factors Market by Hemophilia Type
10.3.6.1.3 South Africa Recombinant Coagulation Factors Market by End User
10.3.6.2 Saudi Arabia Recombinant Coagulation Factors Market
10.3.6.2.1 Saudi Arabia Recombinant Coagulation Factors Market by Product
10.3.6.2.2 Saudi Arabia Recombinant Coagulation Factors Market by Hemophilia Type
10.3.6.2.3 Saudi Arabia Recombinant Coagulation Factors Market by End User
10.3.6.3 U.A.E Recombinant Coagulation Factors Market
10.3.6.3.1 U.A.E Recombinant Coagulation Factors Market by Product
10.3.6.3.2 U.A.E Recombinant Coagulation Factors Market by Hemophilia Type
10.3.6.3.3 U.A.E Recombinant Coagulation Factors Market by End User
10.4. SOUTH AND CENTRAL AMERICA
10.4.1 South and Central America Recombinant Coagulation Factors Market Overview
10.4.2 South and Central America Recombinant Coagulation Factors Market Forecasts and Analysis
10.4.3 South and Central America Recombinant Coagulation Factors Market Forecasts and Analysis - By Product
10.4.4 South and Central America Recombinant Coagulation Factors Market Forecasts and Analysis - By Hemophilia Type
10.4.5 South and Central America Recombinant Coagulation Factors Market Forecasts and Analysis - By End User
10.4.6 South and Central America Recombinant Coagulation Factors Market Forecasts and Analysis - By Countries
10.4.6.1 Brazil Recombinant Coagulation Factors Market
10.4.6.1.1 Brazil Recombinant Coagulation Factors Market by Product
10.4.6.1.2 Brazil Recombinant Coagulation Factors Market by Hemophilia Type
10.4.6.1.3 Brazil Recombinant Coagulation Factors Market by End User
10.4.6.2 Argentina Recombinant Coagulation Factors Market
10.4.6.2.1 Argentina Recombinant Coagulation Factors Market by Product
10.4.6.2.2 Argentina Recombinant Coagulation Factors Market by Hemophilia Type
10.4.6.2.3 Argentina Recombinant Coagulation Factors Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RECOMBINANT COAGULATION FACTORS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. RECOMBINANT COAGULATION FACTORS MARKET, KEY COMPANY PROFILES
13.1. BAXTER INTERNATIONAL INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BAYER AG
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BIOGEN IDEC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CSL LTD.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GRIFOLS INTERNATIONAL SA
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. KEDRION S.P.A.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. NOVO NORDISK A/S
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. OCTAPHARMA AG
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. PFIZER INC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. RAYBIOTECH, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Recombinant Coagulation Factors Market - By Product
1.3.2 Recombinant Coagulation Factors Market - By Hemophilia Type
1.3.3 Recombinant Coagulation Factors Market - By End User
1.3.4 Recombinant Coagulation Factors Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. RECOMBINANT COAGULATION FACTORS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 Europe - Pest Analysis
4.2.2 Asia-Pacific - Pest Analysis
4.2.3 Middle East and Africa - Pest Analysis
4.2.4 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. RECOMBINANT COAGULATION FACTORS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. RECOMBINANT COAGULATION FACTORS MARKET - GLOBAL MARKET ANALYSIS
6.1. RECOMBINANT COAGULATION FACTORS - GLOBAL MARKET OVERVIEW
6.2. RECOMBINANT COAGULATION FACTORS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. RECOMBINANT COAGULATION FACTORS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. RECOMBINANT FACTOR VIII
7.3.1. Overview
7.3.2. Recombinant Factor Viii Market Forecast and Analysis
7.4. RECOMBINANT FACTOR IX
7.4.1. Overview
7.4.2. Recombinant Factor IX Market Forecast and Analysis
7.5. VON WILLEBRAND FACTOR
7.5.1. Overview
7.5.2. Von Willebrand Factor Market Forecast and Analysis
8. RECOMBINANT COAGULATION FACTORS MARKET - REVENUE AND FORECASTS TO 2028 - HEMOPHILIA TYPE
8.1. OVERVIEW
8.2. HEMOPHILIA TYPE MARKET FORECASTS AND ANALYSIS
8.3. HEMOPHILIA A HEMOPHILIA B
8.3.1. Overview
8.3.2. Hemophilia A Hemophilia B Market Forecast and Analysis
9. RECOMBINANT COAGULATION FACTORS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.4. CLINICS
9.4.1. Overview
9.4.2. Clinics Market Forecast and Analysis
9.5. RESEARCH INSTITUTES
9.5.1. Overview
9.5.2. Research Institutes Market Forecast and Analysis
10. RECOMBINANT COAGULATION FACTORS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. EUROPE
10.1.1 Europe Recombinant Coagulation Factors Market Overview
10.1.2 Europe Recombinant Coagulation Factors Market Forecasts and Analysis
10.1.3 Europe Recombinant Coagulation Factors Market Forecasts and Analysis - By Product
10.1.4 Europe Recombinant Coagulation Factors Market Forecasts and Analysis - By Hemophilia Type
10.1.5 Europe Recombinant Coagulation Factors Market Forecasts and Analysis - By End User
10.1.6 Europe Recombinant Coagulation Factors Market Forecasts and Analysis - By Countries
10.1.6.1 Germany Recombinant Coagulation Factors Market
10.1.6.1.1 Germany Recombinant Coagulation Factors Market by Product
10.1.6.1.2 Germany Recombinant Coagulation Factors Market by Hemophilia Type
10.1.6.1.3 Germany Recombinant Coagulation Factors Market by End User
10.1.6.2 France Recombinant Coagulation Factors Market
10.1.6.2.1 France Recombinant Coagulation Factors Market by Product
10.1.6.2.2 France Recombinant Coagulation Factors Market by Hemophilia Type
10.1.6.2.3 France Recombinant Coagulation Factors Market by End User
10.1.6.3 Italy Recombinant Coagulation Factors Market
10.1.6.3.1 Italy Recombinant Coagulation Factors Market by Product
10.1.6.3.2 Italy Recombinant Coagulation Factors Market by Hemophilia Type
10.1.6.3.3 Italy Recombinant Coagulation Factors Market by End User
10.1.6.4 Spain Recombinant Coagulation Factors Market
10.1.6.4.1 Spain Recombinant Coagulation Factors Market by Product
10.1.6.4.2 Spain Recombinant Coagulation Factors Market by Hemophilia Type
10.1.6.4.3 Spain Recombinant Coagulation Factors Market by End User
10.1.6.5 United Kingdom Recombinant Coagulation Factors Market
10.1.6.5.1 United Kingdom Recombinant Coagulation Factors Market by Product
10.1.6.5.2 United Kingdom Recombinant Coagulation Factors Market by Hemophilia Type
10.1.6.5.3 United Kingdom Recombinant Coagulation Factors Market by End User
10.1.6.6 Rest of Europe Recombinant Coagulation Factors Market
10.1.6.6.1 Rest of Europe Recombinant Coagulation Factors Market by Product
10.1.6.6.2 Rest of Europe Recombinant Coagulation Factors Market by Hemophilia Type
10.1.6.6.3 Rest of Europe Recombinant Coagulation Factors Market by End User
10.2. ASIA-PACIFIC
10.2.1 Asia-Pacific Recombinant Coagulation Factors Market Overview
10.2.2 Asia-Pacific Recombinant Coagulation Factors Market Forecasts and Analysis
10.2.3 Asia-Pacific Recombinant Coagulation Factors Market Forecasts and Analysis - By Product
10.2.4 Asia-Pacific Recombinant Coagulation Factors Market Forecasts and Analysis - By Hemophilia Type
10.2.5 Asia-Pacific Recombinant Coagulation Factors Market Forecasts and Analysis - By End User
10.2.6 Asia-Pacific Recombinant Coagulation Factors Market Forecasts and Analysis - By Countries
10.2.6.1 Australia Recombinant Coagulation Factors Market
10.2.6.1.1 Australia Recombinant Coagulation Factors Market by Product
10.2.6.1.2 Australia Recombinant Coagulation Factors Market by Hemophilia Type
10.2.6.1.3 Australia Recombinant Coagulation Factors Market by End User
10.2.6.2 China Recombinant Coagulation Factors Market
10.2.6.2.1 China Recombinant Coagulation Factors Market by Product
10.2.6.2.2 China Recombinant Coagulation Factors Market by Hemophilia Type
10.2.6.2.3 China Recombinant Coagulation Factors Market by End User
10.2.6.3 India Recombinant Coagulation Factors Market
10.2.6.3.1 India Recombinant Coagulation Factors Market by Product
10.2.6.3.2 India Recombinant Coagulation Factors Market by Hemophilia Type
10.2.6.3.3 India Recombinant Coagulation Factors Market by End User
10.2.6.4 Japan Recombinant Coagulation Factors Market
10.2.6.4.1 Japan Recombinant Coagulation Factors Market by Product
10.2.6.4.2 Japan Recombinant Coagulation Factors Market by Hemophilia Type
10.2.6.4.3 Japan Recombinant Coagulation Factors Market by End User
10.2.6.5 South Korea Recombinant Coagulation Factors Market
10.2.6.5.1 South Korea Recombinant Coagulation Factors Market by Product
10.2.6.5.2 South Korea Recombinant Coagulation Factors Market by Hemophilia Type
10.2.6.5.3 South Korea Recombinant Coagulation Factors Market by End User
10.3. MIDDLE EAST AND AFRICA
10.3.1 Middle East and Africa Recombinant Coagulation Factors Market Overview
10.3.2 Middle East and Africa Recombinant Coagulation Factors Market Forecasts and Analysis
10.3.3 Middle East and Africa Recombinant Coagulation Factors Market Forecasts and Analysis - By Product
10.3.4 Middle East and Africa Recombinant Coagulation Factors Market Forecasts and Analysis - By Hemophilia Type
10.3.5 Middle East and Africa Recombinant Coagulation Factors Market Forecasts and Analysis - By End User
10.3.6 Middle East and Africa Recombinant Coagulation Factors Market Forecasts and Analysis - By Countries
10.3.6.1 South Africa Recombinant Coagulation Factors Market
10.3.6.1.1 South Africa Recombinant Coagulation Factors Market by Product
10.3.6.1.2 South Africa Recombinant Coagulation Factors Market by Hemophilia Type
10.3.6.1.3 South Africa Recombinant Coagulation Factors Market by End User
10.3.6.2 Saudi Arabia Recombinant Coagulation Factors Market
10.3.6.2.1 Saudi Arabia Recombinant Coagulation Factors Market by Product
10.3.6.2.2 Saudi Arabia Recombinant Coagulation Factors Market by Hemophilia Type
10.3.6.2.3 Saudi Arabia Recombinant Coagulation Factors Market by End User
10.3.6.3 U.A.E Recombinant Coagulation Factors Market
10.3.6.3.1 U.A.E Recombinant Coagulation Factors Market by Product
10.3.6.3.2 U.A.E Recombinant Coagulation Factors Market by Hemophilia Type
10.3.6.3.3 U.A.E Recombinant Coagulation Factors Market by End User
10.4. SOUTH AND CENTRAL AMERICA
10.4.1 South and Central America Recombinant Coagulation Factors Market Overview
10.4.2 South and Central America Recombinant Coagulation Factors Market Forecasts and Analysis
10.4.3 South and Central America Recombinant Coagulation Factors Market Forecasts and Analysis - By Product
10.4.4 South and Central America Recombinant Coagulation Factors Market Forecasts and Analysis - By Hemophilia Type
10.4.5 South and Central America Recombinant Coagulation Factors Market Forecasts and Analysis - By End User
10.4.6 South and Central America Recombinant Coagulation Factors Market Forecasts and Analysis - By Countries
10.4.6.1 Brazil Recombinant Coagulation Factors Market
10.4.6.1.1 Brazil Recombinant Coagulation Factors Market by Product
10.4.6.1.2 Brazil Recombinant Coagulation Factors Market by Hemophilia Type
10.4.6.1.3 Brazil Recombinant Coagulation Factors Market by End User
10.4.6.2 Argentina Recombinant Coagulation Factors Market
10.4.6.2.1 Argentina Recombinant Coagulation Factors Market by Product
10.4.6.2.2 Argentina Recombinant Coagulation Factors Market by Hemophilia Type
10.4.6.2.3 Argentina Recombinant Coagulation Factors Market by End User
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL RECOMBINANT COAGULATION FACTORS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. RECOMBINANT COAGULATION FACTORS MARKET, KEY COMPANY PROFILES
13.1. BAXTER INTERNATIONAL INC.
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. BAYER AG
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BIOGEN IDEC
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. CSL LTD.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. GRIFOLS INTERNATIONAL SA
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. KEDRION S.P.A.
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. NOVO NORDISK A/S
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. OCTAPHARMA AG
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. PFIZER INC
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. RAYBIOTECH, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
1. Baxter International Inc.
2. Bayer AG
3. Biogen Idec
4. CSL Ltd.
5. Grifols International SA
6. Kedrion S.P.A.
7. Novo Nordisk A/S
8. Octapharma AG
9. Pfizer Inc
10. RayBiotech, Inc.
2. Bayer AG
3. Biogen Idec
4. CSL Ltd.
5. Grifols International SA
6. Kedrion S.P.A.
7. Novo Nordisk A/S
8. Octapharma AG
9. Pfizer Inc
10. RayBiotech, Inc.
Get the Latest COVID-19 Analysis on this market
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak To Analyst
Pricing
-
$3000
-
$4550
-
$6550
-
$8550
-
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.
Inquire for Discount